click any menu and scroll down to see the information

Editor in Chief: Dr. Md. Saiful Islam Khan

BSc (Hon’s), MSc (Plant Biotechnology), Doctor of Philosophy (Shizuoka University, Japan)

The Journal of Drug Development and Biomedicine is a scientific publication dedicated to the dissemination of research in the fields of pharmaceutical sciences, drug development, and biomedicine. It serves as a platform for researchers, scientists, and clinicians to share their latest findings and advancements in the understanding and development of novel therapeutic agents, drug delivery systems, and biomedical innovations.

Frequency: 1 Volume, 6 Issues per Year

[1] Jan-February

[2] March-April

[3] May-June

[4] July-August

[5] September-October

[6] November-December

Aim and Scope

The journal of Drug Development and Biomedicine is an open-access journal that promotes drug development and biomedical science. It publishes original research articles, reviews, and clinical studies that investigate the discovery, design, development, and evaluation of pharmacological and biotechnological molecules

The journal’s focus is to communicate high-quality, methodologically sound research that advances our understanding and knowledge of drug development and biomedical sciences. It accepts submissions in the following areas:

  • Drug Discovery and Design: Innovations in the identification and design of new therapeutic agents.
  • Pharmacology: Studies on the biological effects and mechanisms of action of drugs.
  • Pharmacokinetics and Pharmacodynamics: Research on the absorption, distribution, metabolism, excretion, and effects of drugs.
  • Drug Delivery Systems: Development of novel methods for the targeted and controlled delivery of drugs.
  • Biotechnology: Advancements in the use of biological systems and organisms in drug development.
  • Clinical Trials and Studies: Clinical evaluations of new drugs and therapeutic interventions.

By focusing on these topics, the journal seeks to bridge the gap between laboratory research and clinical application, thereby promoting the development of effective and safe therapeutic solutions.

Editorial Board

Editor in Chief

Dr. Md. Saiful Islam Khan

BSc (Hon’s), MSc (Plant Biotechnology), Doctor of Philosophy (Shizuoka University, Japan)

Editorial Board Members

Dr. Nazrul Islam

BSc (Hon’s), MSc (Biological Science), Doctor of Philosophy (Shizuoka University, Japan)

Md. Abdul Bari

BSc (Hon’s), MSc (Zoology) Principal Scientific Officer
Bangladesh Atomic Energy Commission

Dhaka, Bangladesh.

Dr. Santosh Mazumder

BSc (Hon’s), MSc, PhD (Zoology) Chittagong University

Bangladesh

Article Processing Charge

The Article Processing Charge (APC) for the Journal of Drug Development and Biomedicine is a fee that covers the costs of the editorial process, review, and open access publication. This fee guarantees that publications are freely accessible to readers globally without the need for a subscription, enabling the wider distribution and impact of research findings. The APC is normally assessed after the manuscript has been accepted following the peer-review process. The APC for each article is US$50. 

Author Instruction

Journal of Drug development and Biomedicine (JDDB) is an open access multidisciplinary journal that publishes original research articles, review articles and short-communication on all areas of medicine, chemistry, biochemistry, biotechnology, life sciences, pharmacology, drug discovery in which new medications are discovered, developed and delivered for various clinical, medical and pharmacological benefits. Submission of manuscript to this journal implies that the work is original. The work has not been published elsewhere and that is not consideration for publication to any other scientific journals.

Scope of the journal

Journal of Drug Development and Biomedicine [JDDB] is an open access journal that publishes high quality Manuscripts in all related aspects covering medicine, chemistry, biochemistry, biotechnology, life sciences, pharmacology, drug discovery in which new medications are discovered, developed and delivered for various clinical, medical and pharmacological benefits. The journal is publishes in both print and online versions.

Manuscript preparation

Contributors submitting manuscript for consideration for publication should follow the following guidelines.

Style and format

Manuscripts should be prepared in MS word format and typewritten on an A4 sheet having ‘1.5’ line-spacing throughout the text. The margins should be 2.54cm (1inch) in all sides and page number should be consecutively on the bottom of the page. The manuscript should be written in Time new roman using ’12’ font size and not exceed 30 pages. Manuscripts must be written in English. For non-native English language authors, the article should be proof read by a language specialist. Poor use of English could result in rejection of the manuscript.

Manuscript content

For original research paper, the manuscript should be arranged in the following order: Title page (Title, Full Author name, Author affiliate address & email of corresponding author), Abstract, keywords, Introduction, Materials and methods, Results, Discussion (this section may be combined with results), Acknowledgements, References, Tables with legends, Figures with legends and Supplementary materials (if applicable).

Title and contact information

The first page should contain the full title, the full names of authors and affiliations of all authors (Department, Faculty, University, City, and Country) including a valid e-mail address for the corresponding author along with telephone and fax numbers. The Title of the manuscript should be specific and concise but sufficiently informative.

 

 

Abstract

The abstract should contain brief summary of findings and conclusion of the study. The abstract should not contain abbreviations references or diagrams. The abstract must not go to more than 300 words each for original and review papers or 150 words for short communications.

Key words

Author should provide no more than 6 key words. The Key words should arrange alphabetically. Acronyms should be avoided.

Introduction

The introduction should be arguing the case study, outlining essential background and the objectives of the work. Avoid a detailed literature survey or a summary of the results.

Materials and methods

The materials and methods section should be include sufficient technical information about the materials and the analytical and statistical procedures used. Describe new methods completely and give sources of useful chemicals and equipment.

Results

Result and discussion can be written separately or combined. The results obtained from the experiments including their statistical evaluation and any explanation should be presented graphically or in tables in this section. This section may be organized into subheadings. Extensive interpretation of the results should be reserved for the Discussion section. Avoid similar data in both table and figure form. Photographs to those that is absolutely necessary to show the experimental findings. Number figures and tables in the order in which they are cited in the text, and be sure to cite all figures and tables.

Discussion

The Discussion section should provide an interpretation of the results in relation to previously published works. It should not contain extensive repetition of the Results section. The Discussion may be organized into subheadings.

Conclusion

In the conclusion section, author should state the most important outcome of the work by interpreting the findings at a higher level of abstraction than the Discussion and by relating these findings to the motivation stated in the Introduction. Do not simply summarize the points already made in the body. Conclusions must not contain references to the cited literature.

Acknowledgements

In this section author should give credit to people who have helped author with the research or with writing the paper. If the author work has been supported by a grant, author should also give credit for that in this section.

 

 

 

Scientific names

Scientific names should be complete and italics (genus, species, and authority, and cultivar where appropriate) for every organism at the first mention. The generic name can be abbreviated from second times. In addition, gene name must be italics.

Nomenclature

Nomenclature for genes and proteins must follow international standards. All gene symbol and loci should be in italics and capital. All chemical, biochemical, and molecular biology nomenclature should be followed by IUBMB recommendation (http://www.chem.qmul.ac.uk/iubmb/). Database for gene or protein sequence or others should be given reference according to EMBL; GenBank, or the Protein Data Bank.

Tables and Figures

  • All illustrations (photographs, drawings, graphs, etc.), not including tables, must be labelled “Figure.” Figures and table must be submitted at the end of the manuscript, after the references, not in the running text.
  • All tables and figures must have a caption and/or legend and be numbered (e.g., Table 1, Figure 2), unless there is only one table or figure, in which case it should be labelled “Table” or “Figure” with no numbering. Captions must be written in sentence case (e.g., Microscopic view of Trichoderma.). The font used in the figures should be Times New Roman.

Symbols, units, and abbreviations

  • In general, the journal follows CSE Style and Format, The CSE Manual for Authors, Editors, and Publishers, Council of Science Editors, Reston, VA, USA (7th ed.).
  • If symbols such as ×, µ, η, or ν are used, they should be added using the Symbols menu of Word.
  • Degree symbols (°) must be used from the Symbol menu, not superscripted letter o or number 0.
  • The International System of Units (SI) should be employed for measurements. When one unit appears in a denominator, the unit should be presented as a fraction (g/m2); for two or more units in a denominator, use negative exponents (g m-2 d-l).
  • Insert one space between figures and units, except for % and units of temperature, latitude, and longitude (e.g., 5 m, 55 ℃, 500 kg).
  • Times of day should be presented using a 24 hour clock (e.g., 0800 hr, 2.030 hr). Dates should be presented as for example, 30 Jan 2013.
  • In the text, numbers should be Arabic numerals, except when beginning a sentence. Numbers greater than 999 should have commas (e.g., 10,000).
  • Spaces must be inserted between numbers and units (e.g., 3 kg) and between numbers and mathematical symbols (+, –, ×, =, ), but not between numbers and percent symbols (e.g., 45%).
  • All abbreviations and acronyms should be defined at first mention. Latin terms such as et al., in vitro, or in situ should not be italicized.
  • Common molecular, chemical, immunological, and hematological terms can be used without definition in the title, abstract, text, tables, and figure legends (e.g., bp, kb, kDa, DNA, cDNA, RNA, mRNA, PCR, SDS-PAGE, ELISA, IgG, RBC, and WBC). Other common abbreviations are as follows (the same abbreviations are used for plural forms): hr (hour; use 0-24:00 h for time), sec (second), min (minute), day (not abbreviated), week (not abbreviated), month (not abbreviated), year (not abbreviated), L (liter), mL (milliliter), μL (microliter), g (gram), kg (kilogram), mg (milligram), μg (microgram), ng (nanogram), pg (picogram), g (gravity; not × g), n (sample size), SD (standard deviation of the mean), SE (standard error of the mean).

Statistical analysis

Statistical analysis is to be done if necessary. Biological data without statistical analysis cannot be accepted.

References

The manuscript should be checked carefully to ensure that the spellings of the authors’ names and the years are exactly the same in the text as given in the reference list.

  • Unpublished results and personal communications are not recommended in the reference list, but may be mentioned in the text. If these references are included in the reference list they should include a substitution of the publication date with either ‘Unpublished results’ or ‘Personal communication’.
  • Citation of a reference as ‘in press’ implies that the item has been accepted for publication.
  • In the case of publications in languages other than English, the published English title should be provided. If the publication is not published with an English title, provide the original title only; do not provide a self-translation.

Citation in the text

  • In-text citations appear in brackets, and consist of the author(s) last name, as well as the document’s year of publication (e.g. Rahman 2012). The end reference list appears in alphabetical order by author last name.
  • If the author’s name is clearly mentioned in the text, it can be directly followed by the year of publication, in parentheses: Zakaria (2020) isolated and identified 5 species of Trichoderma from the rhizosphere of rubber trees in Malaysia, namely…..
  • If a document has two authors, include both surnames separated by “and”. For works with three or more authors, include only the first author name, followed by “et al.”: … (Rahman and Illias 2012). … (Rahman et al. 2013).
  • If the author cites several sources at once, list them in chronological order, or alphabetically if two or more works were published in the same year, and separate each one with a semicolon: … (Rahman, 1963; Rahman and Alam, 1975; Beagum, 1975; Alam et al. 1992).
  • Citing two or more works written by the same author in the same year, add a designator (a, b, c…) to distinguish them.

(Rahman 2011a, 2011b).

Use the same designators in the reference list: …

Rahman MA. 2011a. Isolation and Identification…

Rahman MA. 2011b. Screening of Trichoderma spp. and …

  • If the author would like to cite a source that is cited in another document, it is always best to consult and cite the original source. The original author can be acknowledged within the text, but only the item seen appears in the reference list. … (Rahman, 2001, cited in Alam, 2010) or … Alam (2010) describes Rahman 2001 study on… In this example, the reference list would include only Alam work: Alam, M. F. 2010. The Commonwealth of Life: Economics for a Flourishing Earth. 2nd ed. Montreal (QC): Black Rose Books.
  • If the author of a document is an organization, corporation, government department, university, etc., use an abbreviated form of the organization in the in text citation, by retaining the first letter of each word in the name, or some other recognized abbreviation:

UNESCO. 2006.

Reference list

Compile all references together in a list at the end of the manuscript text. Authors must reference all previous publications in which portions of the present work has appeared. Articles accepted for publication should be cited as “in press”; the DOI should be given if the paper is published online only. Journal of Drug Development and Biomedicine [JDDB] will use the following reference style for published articles.  

References should be listed alphabetically. Abbreviated journals names must be written, not full name of journal.

Author’s Names

  • The names of authors are written in reverse order. Include the initials for the first and middle names. End this information with a period.

Example: Full name: Mohammad Ahsanur Rahman

Structure: Last name, First initial. Middle initial.

Example: Rahman, M. A.

Two or More Authors        

  • When two or more authors work together on a source, write them in the order in which they appear on the source, using this format:

Structure:  Last name, F. M.; Last name, F. M.; Last name, F. M.; Last name, F. M.; Last name, F. M.

Example: Rahman, M. A.; Begum, M. F.; Rahman, M. M.; Bari, M. A.; Ilias, G. N. M.; Alam, M. F.

Journal article

For journals

Structure: Author(s) last name, First initial. Middle initial. Article title. Abbreviated journal name in italic. Year, Volume (Issue), Pages.

Example: Rahman, M. A.; Begum, M. F.; Rahman, M. M.; Bari, M. A.; Ilias, G. N. M.; Alam, M. F. Isolation and identification of Trichoderma species from different habitats and their use for bioconversion of organic solid waste. Turk.  J. Biol. 2009, 35(2), 183-194.

For journal articles published online ahead of print or online only, the DOI should be used:

Rahman, M. A.; Moni, Z. R.; Hussen, M. A.; Ansari, T. H. Prevalence of fungal diseases in medicinal plants in northern region of Bangladesh. SAARC J. Agric. 2009, 17(2), 197-212. DOI: https://doi.org/10.3329/sja.v17i2.45306

For Books

Structure: Author(s). Book Title (In Italic), Edition,; Publisher: Place of Publication, Year; pages.

Example: Falero, E. M.; Fernandez, S. M.; Antonio, D.; Abril, G. Quantitative techniques in participatory forest management. 4th ed.; Bota, R., Ed.; Academic Press: New York, 2003; pp 1-39.

Chapter in a book

Structure: Author(s). Book title (In italic). Edition.; Publisher: Place of Publication. Chapter #, Chapter title, Year; pp. Pages of the chapter.

Example: Shmulsky, R.; Jones, D. P. Forest product and wood science an introduction. 6th ed.; John Wiley & Sons: Surrey (U.K). Chapter 6, Juvenile wood, reaction wood, and wood of branches; pp 107-139.

Thesis or dissertation

Structure: Author. Title of the Thesis. Level of Thesis, Degree-Granting University, Location of University, Date of Completion.

Example:

  1. Rahman, M. A. Screening of Trichoderma and their efficacy as a bioconversion agent of municipal solid waste through appropriate technique of solid state fermentation. Ph.D. Dissertation, University of Rajshahi, Bangladesh, 2009.
  2. Mäckel, H. Capturing the spectra of silicon solar cells. Ph.D. Thesis, The Australian National University, December 2004.

Conference papers or proceedings

Manly, S. Collective flow with PHOBOS. Presented at the 20th Winter Workshop on Nuclear Dynamics [Online], Trelawny Beach, Jamaica, March 15–20, 2004. University of Rochester, DSpace Web site. http://hdl.handle.net/1802/228 (accessed Oct 13, 2004).

 

Structure: Author(s). Title of paper/presentation. Presented at conference title [Online], Place, Date; Paper Number. Title of the Site. URL (accessed Month Day, Year).

 

Example: Torreta, N. K.; Takeda, H.; Azuma, J. I. Presented at the 20th Winter Workshop on Nuclear Dynamics [Online], Trelawny Beach, Jamaica, March 15–20, 2004. University of Rochester, DSpace Web site. http://hdl.handle.net/1802/228 (accessed Oct 13, 2004).

 

Online source

For online articles provided as content in a subscription database, use the reference style for periodicals or nonscientific magazines as appropriate, and include the name of the database provider, the URL of the top page, and the date accessed.

Example: Hallet, V. Scanning the Globe for Organic Chemistry. U.S. News and World Report [Online], April 19, 2004, p 59. Business Source Premier. http://www.epnet. com/academic/bussourceprem.asp (accessed April 24, 2005).

Articles published online

Structure: Authors. Title of Article. Journal Abbreviation [Online early access]. DOI or other identifying information. Published Online: Month Day, Year. URL (accessed Month Day, Year).

Example:

Rahman, M. A,; Begum, M. F.; Alam, M. F. Screening of Trichoderma Isolates as a biological control agent against Ceratocystis paradoxa causing pineapple disease of Sugarcane. Mycobiology. [Online early access]. DOI:  10.4489/MYCO.2009.37.4.277. Published Online: December 31, 2009. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749418/. htm (accessed September 20, 2020).

Electronic book

Books published online generally correspond to printed versions, and the reference styles are similar. Online location and access date should always be included when citing online books. Reference works published online are often updated with new content, and the dates on which sections were posted or updated should also be included.

Structure: Author(s). Book Title [Online]; Series Information (if any); Publisher: Place of Publication, Year, Volume Number, Pagination. URL (accessed Month Day, Year).

Example: Grebner, D.; Bettinger, P.; Siry, J. Introduction to Forestry and Natural Resources [Online]; Academic Press, Amsterdam, 2013; pp 177-180. https://www.sciencedirect.com/science/book/9780123869012 [accessed 2017 Dec 30].

Online books with editors

Authors. Chapter Title. In Book Title [Online]; Editor 1, Editor 2, etc., Eds.; Series Information (if any); Publisher: Place of Publication,Year; Volume Number, Pagination. URL (accessed Month Day, Year).

Oleksyn, B. J.; Stadnicka, K.; Sliwinski, J. Structural Chemistry of Enamines: A Statistical Approach. In The Chemistry of Enamines [Online]; Rappoport, Z., Ed.; The Chemistry of Functional Groups; Patai, S., Rappoport, Z., Series Eds.; Wiley & Sons: New York, 1994; Chapter 2, pp 87–218. http://www3. interscience.wiley.com/cgi-bin/summary/109560980/SUMMARY (accessed April 24, 2005).

Online encyclopedias

Structure: Article Title. Encyclopedia Title, edition [Online]; Publisher, Posted Online Posting Date. URL (accessed Month Day, Year).

Example: Alkanolamines from Nitro Alcohols. Kirk-Othmer Encyclopedia of Chemical Technology [Online]; Wiley & Sons, Posted March 14, 2003. http://www.mrw. interscience.wiley.com/kirk/articles/alkaboll.a01/frame.html (accessed Nov 7, 2004).

Publication Ethics

The Journal of Drug Development and Biomedicine is committed to sustaining the highest levels of publication ethics, assuring the integrity and quality of the research it publishes. While precise information regarding this journal’s ethical standards is not easily available, journals in this discipline are known to follow established ethical norms and practices.

Many respected journals adhere to the Committee on Publication Ethics’ (COPE) core standards, which provide detailed recommendations for editors and publishers on how to address incidents of research and publication misconduct.

Furthermore, publications frequently follow the International Committee of Medical Journal Editors’ (ICMJE) recommendations, which stress the roles of authors, editors, and reviewers in upholding ethical standards. Common ethical considerations in reputable journals include:

  • Authorship and Contribution: Ensuring that all listed authors contributed significantly to the research and manuscript preparation.
  • Conflict of Interest: Authors, reviewers, and editors must state any potential conflicts of interest that may have an impact on the study or review process.
  • Data Integrity: Requiring correct reporting of study findings without fabrication, falsification, or improper data manipulation.
  • Plagiarism Prevention: Requiring correct reporting of study findings without fabrication, falsification, or improper data manipulation.
  • Ethical Research Conduct: All study involving human or animal participants must adhere to relevant ethical standards and obtain proper clearances.

Policies and Statements

The journal of Drug Development and Biomedicine is an open access journal that focuses on quality pharmaceutical discoveries and developments. It publishes research reports, review articles, and scientific commentaries on a wide range of pharmaceutical sciences topics, including medicinal chemistry, pharmacology, drug absorption and metabolism, pharmacokinetics and pharmacodynamics, pharmaceutical and biomedical analysis, drug delivery systems, pharmaceutical technology, biotechnology, and clinical drug evaluation.

Editorial Policies:

Open Access: JDDB operates under an open-access model, which implies that all published content is freely available to readers.

Review Process: The journal maintains high-quality manuscripts through a rigorous review process. Experts in the field assess articles to ensure their scientific validity and application.

Ethical Guidelines: When conducting research and publishing, authors must adhere to ethical rules. Comprehensive standards are proposed to ensure respect to moral values.

Submission and Contact Information: Authors can submit manuscripts through the journal’s submission portal or via email to the Editorial Office at editor@imedpub.com.

Editorial Workflow

The editorial workflow of the Journal of Drug Development and Biomedicine is typically designed to assure the publication of high-quality research. While the details can vary substantially from journal to journal, the general approach generally comprises the following steps:

  1. Manuscript Submission

Author’s Responsibility: The method begins when an author submits a work for consideration. The manuscript is frequently submitted via an email submission system.

Pre-submission Checks: The editing team conducts a preliminary check to confirm compliance with submission standards, formatting, and ethical considerations.

  1. Initial Editorial Assessment

Editor’s Review: The managing editor, who is typically a plant protection expert, does a preliminary assessment. This review assesses the manuscript’s suitability for publication based on its relevance to the journal’s scope, scientific quality, and novelty.

Decision Making: The editor determines whether to forward the manuscript for review, reject it entirely, or seek adjustments for resubmission.

  1. Review

Selection of Reviewers: If the document passes the initial review, it is assigned to other peer reviewers. The editor selects reviewers based on their plant protection experience, ensuring a fair and objective review process.

Review Process: Reviewers evaluate the manuscript’s scientific validity, methods, findings, and contribution to the area. They provide feedback on the manuscript’s merits, weaknesses, and potential areas for improvement.

Reviewer Comments: After completing the review, the reviewers submit their comments to the editor. Depending on the research’s quality and originality, feedback can range from minor revisions to rejection.

  1. Decision on Manuscript

Editor’s Decision: The editor decides on the content depending on the reviewers’ feedback. Common choices are:

Accept: If the manuscript is deemed acceptable with no minor adjustments.

Minor Revisions: Minor adjustments are requested from the authors in order to improve the work.

Major Revisions: Significant changes or clarifications are necessary, and the document is re-evaluated after alterations.

Reject: If the work is rejected for publication due to errors in approach, analysis, or relevance.

Notification to Authors: The decision and the reviewer comments are relayed to the authors. The writers make any necessary adjustments to their article.

  1. Revisions and Resubmission

Author’s Role: In a revised publication, the authors address the reviewers’ comments and recommendations. They may need to revise their interpretation of the results, clarify some aspects of the approach, or provide further data.

Resubmission: The corrected document has been sent back for review. It may occasionally be returned for a second evaluation by the original reviewers or new reviewers.

  1. Final Acceptance

Final Review: Following the completion of all modifications, the editor does a final review of the manuscript to ensure that all of the reviewers’ concerns have been handled appropriately.

Acceptance: The manuscript is accepted for publication if it meets the journal’s criteria.

  1. Proofreading and Copyediting

Production Process: Following acceptance, the manuscript is proofread and copyedited to ensure that it is clear, consistent, and meets the journal’s formatting and style criteria.

Author Approval: The authors may be asked to review the revised paper for any final changes or adjustments.

  1. Publication

Online First: Following final approval, the paper is made available online, either in early release or as a preprint.

Issue Publication: After that, the work is published in a regular issue of the journal, either online or in print.

  1. Post-Publication

Promotion: To enhance reading and citation, the journal may promote the paper on social media, email newsletters, or through other outreach tactics. Throughout the workflow, transparency, rigor, and commitment to ethical norms are critical to the journal’s credibility and effect.

Manuscript submission

The Journal of Drug Development and Biomedicine is an open access journal dedicated to publishing high-quality research in the fields of pharmaceutical sciences, biomedical advancements, and interdisciplinary studies related to drug discovery and development. Researchers and academics are encouraged to contribute original manuscripts, reviews, case studies, and short communications.

 
Manuscript Submission Guidelines
  1. Scope of Submission

The journal accepts manuscripts covering topics such as:

  • Drug design, synthesis, and discovery
  • Pharmacokinetics and pharmacodynamics studies
  • Biomedical research advancements
  • Clinical trials and their methodologies
  • Innovative drug delivery systems
  • Biotechnological approaches in drug development
  • Pharmaceutical chemistry and toxicology

 

  1. Preparation of Manuscripts
    • Format: Manuscripts should be submitted in English, formatted as per the journal’s guidelines.
    • Structure:
      • Title Page: Title, authors’ names, affiliations, and corresponding author contact details.
      • Abstract: A concise summary of the research, limited to 250 words.
      • Keywords: 4–6 relevant keywords.
      • Main Text: Divided into Introduction, Materials and Methods, Results, Discussion, Conclusion, and References sections.
    • References: Follow the journal’s citation style (usually Vancouver or APA). Use reference management software for accuracy.
    • Figures and Tables: Include high-resolution figures and well-formatted tables with appropriate captions.
  2. Ethical Considerations
    • Manuscripts should adhere to ethical standards, ensuring proper approvals for animal or human studies.
    • Authors must disclose any conflicts of interest.
    • The journal has a strict policy against plagiarism. Submissions are screened using plagiarism detection software.
  3. Submission Process
    • Submissions are made online through the journal’s email submission system.
    • Authors must register on the platform, upload their manuscripts in the prescribed format, and provide supplementary documents like cover letters and coppy right agreement certificates.
  4. Review Process
    • The journal follows a double-blind peer review
    • Authors may suggest potential reviewers, but the editorial board reserves the right to make final decisions.
  5. Post-Acceptance
    • Once accepted, manuscripts undergo professional editing and formatting.
    • Authors receive galley proofs for final approval before publication.
  6. Publication Fees
    • Details on article processing charges (APC), are provided on the journal’s website.
  7. Open Access and Visibility
    • The journal offers open-access publication to ensure global reach and visibility for the authors’ work.
Benefits of Publishing with the Journal
  • Fast and transparent review process.
  • Opportunities for cross-disciplinary collaboration.